Rao, B., Wang, D., Yang, M., Zhao, C., Cheng, M., Li, S., . . . Ren, Z. (2025). Real-world effectiveness and safety of oral Azvudine versus Paxlovid for COVID-19 in patients with kidney disease. BMC Infectious Diseases, 25(1), 1. https://doi.org/10.1186/s12879-025-10643-w
Chicago-referens (17:e uppl.)Rao, Benchen, et al. "Real-world Effectiveness and Safety of Oral Azvudine Versus Paxlovid for COVID-19 in Patients with Kidney Disease." BMC Infectious Diseases 25, no. 1 (2025): 1. https://doi.org/10.1186/s12879-025-10643-w.
MLA-referens (9:e uppl.)Rao, Benchen, et al. "Real-world Effectiveness and Safety of Oral Azvudine Versus Paxlovid for COVID-19 in Patients with Kidney Disease." BMC Infectious Diseases, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12879-025-10643-w.
